Skip to main content

ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) Prévisions des stocks 2025 - Prédiction et analyse des prix de l'IA


ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) Prévisions du cours de l'action AI et analyse des investissements

ALEXANDRIA REAL ESTATE EQUITIES, INC. Graphique du cours de l'action et analyse technique

Chargement ALEXANDRIA REAL ESTATE EQUITIES, INC. graphique interactif des prix et analyse technique...

ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) - Analyse complète des actions et recherche en matière d'investissement

Deep dive into ALEXANDRIA REAL ESTATE EQUITIES, INC.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about ALEXANDRIA REAL ESTATE EQUITIES, INC., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

Pour ALEXANDRIA REAL ESTATE EQUITIES, INC.: ALEXANDRIA REAL ESTATE EQUITIES, INC. operates in the Real Estate & Construction sector, positioning it as a large-cap market leader.

ALEXANDRIA REAL ESTATE EQUITIES, INC. (Symbole boursier: ARE) est une entreprise leader dans le secteur Real Estate & Construction. , opérant spécifiquement dans le secteur Real Estate Investment Trusts..

L'organisation emploie environ 604 professionnels dans le monde entier. .

L'entreprise s'est imposée comme un leader majeur du marché bénéficiant d'un soutien institutionnel important.

Understanding Financial Performance

Ce que signifient ces indicateurs: Key financial indicators showing ALEXANDRIA REAL ESTATE EQUITIES, INC.'s revenue scale, profitability, market value, and shareholder returns.

Comment les lire: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Pour ALEXANDRIA REAL ESTATE EQUITIES, INC.: With $2249M in annual revenue and 18,0% net margin, the company demonstrates exceptional profitability.

Recettes annuelles: $2249 millions d'euros générer une 18,0% marge bénéficiaire nette .

Capitalisation boursière: $18109 millions d'euros - Classé comme actions de grande capitalisation avec une stabilité de niveau institutionnel.

Rendement des fonds propres (ROE): 2,7% - Inférieur à la moyenne l'efficacité du rendement de l'actionnaire, indiquant domaines d'amélioration opérationnelle.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for ALEXANDRIA REAL ESTATE EQUITIES, INC. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

Pour ALEXANDRIA REAL ESTATE EQUITIES, INC.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Débloquer les prédictions Premium de l'IA pour accéder à nos prévisions avancées d'apprentissage automatique pour l'action ALEXANDRIA REAL ESTATE EQUITIES, INC., y compris des objectifs de prix à 7, 30 et 90 jours avec des intervalles de confiance et des évaluations de risque.

Understanding Market Position

What this analysis covers: ALEXANDRIA REAL ESTATE EQUITIES, INC.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

Pour ALEXANDRIA REAL ESTATE EQUITIES, INC.: Strong free cash flow generation demonstrates solid operational efficiency.

L'entreprise ALEXANDRIA REAL ESTATE EQUITIES, INC. est stratégiquement compétitive dans le secteur très dynamique de l'industrie automobile. Real Estate Investment Trusts marché, se positionner en tant que leader dominant du marché des grandes capitalisations, avec d'importantes marges de manœuvre concurrentielles et la confiance des investisseurs institutionnels .

L'entreprise fait preuve d'une grande efficacité opérationnelle en générant un flux de trésorerie disponible d'un montant annuel de __989 millions de dollars., complétée par une impressionnante 29,1% croissance des flux de trésorerie d'une année sur l'autre.

L'entreprise conserve une marge brute 70,3% saine, ce qui témoigne d'un pouvoir de fixation des prix et d'une efficacité opérationnelle solides.

ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) Analyse fondamentale et données sur les délits d'initiés (Rapports financiers trimestriels)

Données financières trimestrielles complètes, tendances en matière de bénéfices, transactions d'initiés et participations institutionnelles pour ALEXANDRIA REAL ESTATE EQUITIES, INC. analyse des actions.

Chargement ALEXANDRIA REAL ESTATE EQUITIES, INC. analyse fondamentale complète et données sur les délits d'initiés...

Plongez au cœur de la santé financière de ALEXANDRIA REAL ESTATE EQUITIES, INC., de ses indicateurs de valorisation et de son efficacité opérationnelle pour prendre des décisions d'investissement éclairées.

Comprendre les paramètres d'évaluation

Ce que signifient ces indicateurs: Les indicateurs de valorisation permettent de déterminer si le prix de l'action ALEXANDRIA REAL ESTATE EQUITIES, INC. est juste par rapport à ses bénéfices, ses actifs et sa position sur le marché.

Comment les lire: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

Pour ALEXANDRIA REAL ESTATE EQUITIES, INC.: Avec un ratio P/E de 55,75, le marché des perspectives de croissance future très appréciées.

P/E Ratio 55,75x
P/B Ratio 1,05x
Market Cap $18109M
Dividend Yield 7,77%
EPS $-0,13
Valeur comptable/action $79,70
Recettes/actions $14,70
FCF/action $7,29
Comprendre les indicateurs de rentabilité

Ce que signifient ces indicateurs: Ces ratios mesurent l'efficacité avec laquelle ALEXANDRIA REAL ESTATE EQUITIES, INC. convertit les revenus en profits et génère des bénéfices pour les actionnaires.

Comment les lire: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Pour ALEXANDRIA REAL ESTATE EQUITIES, INC.: Un ROE de 2,7% indique qu'il existe une marge d'amélioration en ce qui concerne création de valeur pour l'actionnaire.

ROE 2,7%
ROA 1,4%
ROIC 2,0%
Gross Margin 70,3%
Operating Margin 24,1%
Net Margin 18,0%
EBT Margin 22,7%
Comprendre les indicateurs de santé financière

Ce que signifient ces indicateurs: Ces ratios évaluent la capacité de ALEXANDRIA REAL ESTATE EQUITIES, INC. à faire face à ses obligations à court terme et à gérer efficacement ses niveaux d'endettement.

Comment les lire: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

Pour ALEXANDRIA REAL ESTATE EQUITIES, INC.: Un ratio de liquidité générale de 0,78_. suggère des problèmes potentiels de liquidité.

Current Ratio 0,78x
Quick Ratio 0,63x
D/E Ratio 0,63x
Financial Leverage 1,94x
Interest Coverage 4,8x
Working Capital $-456M
Comprendre les indicateurs de flux de trésorerie

Ce que signifient ces indicateurs: Les indicateurs de flux de trésorerie révèlent la capacité de ALEXANDRIA REAL ESTATE EQUITIES, INC. à générer des liquidités à partir de ses activités et à financer ses initiatives de croissance.

Comment les lire: Il est essentiel de disposer d'un flux de trésorerie d'exploitation positif. Le flux de trésorerie disponible indique l'argent disponible pour les dividendes, les rachats ou les investissements.

Pour ALEXANDRIA REAL ESTATE EQUITIES, INC.: Flux de trésorerie disponible de $989M offre une certaine flexibilité pour les rendements des actionnaires et les investissements de croissance.

Operating Cash Flow $989M
Free Cash Flow $989M
Capital Spending $-735M
OCF Growth YoY 29,1%
FCF Growth YoY 29,1%
FCF/Sales 44,0%
CapEx/Sales 146,0%
Comprendre les mesures d'efficacité opérationnelle

Ce que signifient ces indicateurs: Ces ratios mesurent l'efficacité avec laquelle ALEXANDRIA REAL ESTATE EQUITIES, INC. utilise ses actifs et gère son fonds de roulement.

Comment les lire: Des taux de rotation plus élevés indiquent une utilisation efficace des actifs. Des délais de recouvrement plus courts témoignent d'une gestion efficace du crédit.

Pour ALEXANDRIA REAL ESTATE EQUITIES, INC.: Une rotation des actifs de 0,08x laisse entrevoir des possibilités d'amélioration dans les domaines suivants utilisation des actifs.

Asset Turnover 0,08x
Receivables Turnover 297,4x
Fixed Assets Turnover 1,8x
Jours de vente en souffrance 1 jours
Période des dettes 194 jours
Comprendre les données des états financiers

Ce que signifient ces indicateurs: Chiffres clés du compte de résultat et du bilan de ALEXANDRIA REAL ESTATE EQUITIES, INC. montrant la performance financière absolue.

Comment les lire: Les recettes montrent l'ampleur de l'entreprise, tandis que les marges indiquent la rentabilité. Les postes du bilan révèlent la structure financière.

Pour ALEXANDRIA REAL ESTATE EQUITIES, INC.: Avec un chiffre d'affaires annuel de 2249M$, ALEXANDRIA REAL ESTATE EQUITIES, INC. opère à grande échelle.

Compte de résultat ($ Millions d'euros)
Recettes totales $2249M
Revenu d'exploitation $543M
Revenu net $182M
Frais de vente et d'administration $7M
Coût des marchandises vendues $30M
Faits marquants du bilan (% Of Assets)
Total Current Assets 3%
Cash & Short-term Investments 2%
Total Liabilities 43%
Short-term Debt 1%
Accounts Receivable 0%
Informations sur les dividendes et les actionnaires
Dividends Per Share $6,53
Payout Ratio 2,2%
Shares Outstanding 216M
Indicateurs de croissance (en glissement annuel)
EPS Growth 1,8%

Dernières nouvelles ALEXANDRIA REAL ESTATE EQUITIES, INC. Actualités boursières et analyses de marché

Dernières nouvelles, rapports d'analystes et mises à jour du marché concernant le cours de l'action ALEXANDRIA REAL ESTATE EQUITIES, INC. (ARE) et les perspectives d'investissement.

ALEXANDRIA REAL ESTATE EQUITIES, INC. Concurrents et analyse des pairs - Real Estate & Construction Secteur

Analyse comparative de ALEXANDRIA REAL ESTATE EQUITIES, INC. par rapport à ses pairs et à ses concurrents dans le secteur Real Estate & Construction, avec des prévisions alimentées par l'IA et des indicateurs financiers clés.

Entreprise Symbole du téléscripteur Prévisions AI à 90 jours Capitalisation boursière (en millions d'USD) Ratio P/E Rapport P/B
AAT Unlock Forecast - 30 Days FREE Trial $1530M 16,3x 1,3x
ABR Unlock Forecast - 30 Days FREE Trial $2575M 12,0x 0,9x
ABR-PD Unlock Forecast - 30 Days FREE Trial $3979M 18,6x 1,3x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3935M 18,4x 1,3x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4866M 22,8x 1,6x
ACR Unlock Forecast - 30 Days FREE Trial $159M 7,3x 0,4x
ACRE Unlock Forecast - 30 Days FREE Trial $282M 8,5x 0,5x
ACR-PC Unlock Forecast - 30 Days FREE Trial $191M 8,8x 0,5x
ACR-PD Unlock Forecast - 30 Days FREE Trial $167M 7,7x 0,4x
ADC Unlock Forecast - 30 Days FREE Trial $7965M 42,9x 1,4x
ADC-PA Unlock Forecast - 30 Days FREE Trial $2010M 10,8x 0,4x
AGNC Unlock Forecast - 30 Days FREE Trial $10677M 28,3x 1,0x
AGNCL Unlock Forecast - 30 Days FREE Trial $26376M 69,8x 2,6x
AGNCM Unlock Forecast - 30 Days FREE Trial $26043M 68,9x 2,5x
AGNCN Unlock Forecast - 30 Days FREE Trial $26824M 71,0x 2,6x
AGNCO Unlock Forecast - 30 Days FREE Trial $26688M 70,6x 2,6x
AGNCP Unlock Forecast - 30 Days FREE Trial $26230M 69,4x 2,5x
AHR Unlock Forecast - 30 Days FREE Trial $6994M x 2,9x
AHT Unlock Forecast - 30 Days FREE Trial $19M -1,5x -0,1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $54M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $45M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $51M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $45M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $45M x x
AIV Unlock Forecast - 30 Days FREE Trial $3175M -6,0x 34,6x
AJX Unlock Forecast - 30 Days FREE Trial $133M -0,8x 0,5x
AKR Unlock Forecast - 30 Days FREE Trial $2429M 470,2x 1,1x
ALEX Unlock Forecast - 30 Days FREE Trial $1362M 17,5x 1,3x
ALX Unlock Forecast - 30 Days FREE Trial $1230M 32,9x 8,5x
AMH Unlock Forecast - 30 Days FREE Trial $332M 39,2x 0,1x
AMT Unlock Forecast - 30 Days FREE Trial $256324M 198,3x 69,0x
APLE Unlock Forecast - 30 Days FREE Trial $2996M 16,6x 0,9x
ARE Unlock Forecast - 30 Days FREE Trial $18109M 55,8x 1,1x
ARI Unlock Forecast - 30 Days FREE Trial $1525M -9,0x 0,8x
ARR Unlock Forecast - 30 Days FREE Trial $1359M -6,0x 0,8x
ARR-PC Unlock Forecast - 30 Days FREE Trial $1909M x 1,2x
AVB Unlock Forecast - 30 Days FREE Trial $28039M 24,2x 2,4x
BDN Unlock Forecast - 30 Days FREE Trial $764M -5,2x 0,9x
BFS Unlock Forecast - 30 Days FREE Trial $1183M 27,5x 3,7x
BFS-PD Unlock Forecast - 30 Days FREE Trial $826M 19,2x 2,6x
BFS-PE Unlock Forecast - 30 Days FREE Trial $870M 20,2x 2,7x
BHM Unlock Forecast - 30 Days FREE Trial $227M 83,0x 1,7x
BHR Unlock Forecast - 30 Days FREE Trial $597M -3,1x 2,7x
BHR-PB Unlock Forecast - 30 Days FREE Trial $3269M x 14,5x
BHR-PD Unlock Forecast - 30 Days FREE Trial $4058M x 18,0x
BMNM Unlock Forecast - 30 Days FREE Trial $14M x 0,6x
BNL Unlock Forecast - 30 Days FREE Trial $3831M 38,7x 1,3x
BRSP Unlock Forecast - 30 Days FREE Trial $751M -6,6x 0,8x
BRT Unlock Forecast - 30 Days FREE Trial $282M -37,6x 1,5x
BRX Unlock Forecast - 30 Days FREE Trial $8547M 25,5x 2,9x
BXMT Unlock Forecast - 30 Days FREE Trial $3301M -17,4x 0,9x
BXP Unlock Forecast - 30 Days FREE Trial $17511M 3548,3x 3,3x
CBL Unlock Forecast - 30 Days FREE Trial $942M 14,3x 3,3x
CCI Unlock Forecast - 30 Days FREE Trial $46333M 36,6x 6,1x
CDP Unlock Forecast - 30 Days FREE Trial $3618M 24,1x 2,4x
CDR-PB Unlock Forecast - 30 Days FREE Trial $244M 44,3x 10,9x
CDR-PC Unlock Forecast - 30 Days FREE Trial $220M 39,8x 9,8x
CHCT Unlock Forecast - 30 Days FREE Trial $443M -220,9x 1,0x
CHMI Unlock Forecast - 30 Days FREE Trial $106M -9,3x 0,5x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $842M x 3,7x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $882M x 3,8x
CHTH Unlock Forecast - 30 Days FREE Trial $603M x 0,9x
CIM Unlock Forecast - 30 Days FREE Trial $1198M 6,2x 0,5x
CIMN Unlock Forecast - 30 Days FREE Trial $2081M 10,8x 0,8x
CIMO Unlock Forecast - 30 Days FREE Trial $2091M 10,9x 0,8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1862M 9,7x 0,7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $2005M 10,4x 0,8x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1915M 9,9x 0,7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1995M 10,4x 0,8x
CIO Unlock Forecast - 30 Days FREE Trial $280M -15,4x 0,5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $1010M x 1,6x
CLDT Unlock Forecast - 30 Days FREE Trial $388M 41,0x 0,5x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $1101M 116,5x 1,5x
CLPR Unlock Forecast - 30 Days FREE Trial $73M -10,4x -20,5x
CMCT Unlock Forecast - 30 Days FREE Trial $6M -0,1x 0,0x
CMRF Unlock Forecast - 30 Days FREE Trial $1241M x 0,7x
COLD Unlock Forecast - 30 Days FREE Trial $3807M -26,5x 1,2x
CPT Unlock Forecast - 30 Days FREE Trial $12012M 77,0x 2,6x
CSR Unlock Forecast - 30 Days FREE Trial $1156M -74,6x 1,6x
CTO Unlock Forecast - 30 Days FREE Trial $574M 41,8x 1,0x
CTO-PA Unlock Forecast - 30 Days FREE Trial $730M x 1,3x
CTRE Unlock Forecast - 30 Days FREE Trial $6811M 31,0x 2,1x
CUBE Unlock Forecast - 30 Days FREE Trial $9587M 25,6x 3,4x
CUZ Unlock Forecast - 30 Days FREE Trial $4951M 82,2x 1,0x
CXW Unlock Forecast - 30 Days FREE Trial $2336M 22,5x 1,6x
DEA Unlock Forecast - 30 Days FREE Trial $1029M 65,3x 0,8x
DEI Unlock Forecast - 30 Days FREE Trial $5060M 134,2x 2,5x
DHC Unlock Forecast - 30 Days FREE Trial $1053M -1,7x 0,6x
DHCNI Unlock Forecast - 30 Days FREE Trial $4225M -10,4x 2,3x
DHCNL Unlock Forecast - 30 Days FREE Trial $3981M x 2,0x
DLR Unlock Forecast - 30 Days FREE Trial $65148M 47,1x 2,8x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $8355M 6,0x 0,4x
DLR-PK Unlock Forecast - 30 Days FREE Trial $9314M 6,7x 0,4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $8104M 5,9x 0,4x
DOC Unlock Forecast - 30 Days FREE Trial $13554M 82,2x 1,7x
DRH Unlock Forecast - 30 Days FREE Trial $1772M 26,1x 1,1x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5413M 79,8x 3,4x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $1376M 41,8x 1,8x
DX-PC Unlock Forecast - 30 Days FREE Trial $M x x
EARN Unlock Forecast - 30 Days FREE Trial $212M -11,6x 0,9x
EGP Unlock Forecast - 30 Days FREE Trial $8614M 36,4x 2,5x
ELME Unlock Forecast - 30 Days FREE Trial $1507M -114,5x 1,4x
ELS Unlock Forecast - 30 Days FREE Trial $12656M 25,3x 7,3x
EPR Unlock Forecast - 30 Days FREE Trial $0M 18,4x 0,0x
EPR-PC Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PE Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PG Unlock Forecast - 30 Days FREE Trial $M x x
EPRT Unlock Forecast - 30 Days FREE Trial $5895M 26,3x 1,5x
EQC Unlock Forecast - 30 Days FREE Trial $177M 2,3x 0,1x
EQIX Unlock Forecast - 30 Days FREE Trial $76599M 77,1x 5,4x
EQR Unlock Forecast - 30 Days FREE Trial $25472M 28,0x 2,3x
ESRT Unlock Forecast - 30 Days FREE Trial $0M 52,3x 0,0x
ESS Unlock Forecast - 30 Days FREE Trial $17593M 22,0x 3,1x
EXR Unlock Forecast - 30 Days FREE Trial $32754M 33,6x 2,4x
FBRT Unlock Forecast - 30 Days FREE Trial $1023M 9,4x 0,7x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1885M 17,2x 1,3x
FCPT Unlock Forecast - 30 Days FREE Trial $2620M 24,8x 1,8x
FPI Unlock Forecast - 30 Days FREE Trial $521M 53,4x 0,8x
FR Unlock Forecast - 30 Days FREE Trial $6997M 25,8x 2,7x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0,0x 0,0x
FRT Unlock Forecast - 30 Days FREE Trial $9342M 27,0x 2,9x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1959M 5,7x 0,6x
FSP Unlock Forecast - 30 Days FREE Trial $174M -1,9x 0,3x
FVR Unlock Forecast - 30 Days FREE Trial $508M x 1,4x
GIPR Unlock Forecast - 30 Days FREE Trial $-118M -0,8x 17,0x
GIPRW Unlock Forecast - 30 Days FREE Trial $1M x 0,2x
GLPI Unlock Forecast - 30 Days FREE Trial $14728M 20,5x 3,2x
GMRE Unlock Forecast - 30 Days FREE Trial $533M 51,8x 1,1x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $1761M 171,1x 3,5x
GNL Unlock Forecast - 30 Days FREE Trial $1622M -4,5x 0,9x
GPMT Unlock Forecast - 30 Days FREE Trial $146M -0,9x 0,3x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $985M x 1,7x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2685M x 3,1x
HHH Unlock Forecast - 30 Days FREE Trial $3476M -4,8x 1,3x
HIW Unlock Forecast - 30 Days FREE Trial $3601M 27,4x 1,5x
HR Unlock Forecast - 30 Days FREE Trial $5686M -11,5x 1,1x
HST Unlock Forecast - 30 Days FREE Trial $12512M 19,0x 1,9x
HTIA Unlock Forecast - 30 Days FREE Trial $414M -7,6x 0,6x
HTIBP Unlock Forecast - 30 Days FREE Trial $405M -7,3x 0,6x
ICRP Unlock Forecast - 30 Days FREE Trial $81M 7,2x 0,3x
ICR-PA Unlock Forecast - 30 Days FREE Trial $196M 17,3x 0,8x
IHT Unlock Forecast - 30 Days FREE Trial $2M -57,7x 0,6x
ILPT Unlock Forecast - 30 Days FREE Trial $744M -2,3x 1,4x
IMPM Unlock Forecast - 30 Days FREE Trial $2M x x
INN Unlock Forecast - 30 Days FREE Trial $903M 104,9x 1,0x
INN-PE Unlock Forecast - 30 Days FREE Trial $3414M 396,4x 3,8x
INN-PF Unlock Forecast - 30 Days FREE Trial $3372M 391,5x 3,8x
IOR Unlock Forecast - 30 Days FREE Trial $75M 12,5x 0,6x
IRET Unlock Forecast - 30 Days FREE Trial $317M 16,7x 0,5x
IRM Unlock Forecast - 30 Days FREE Trial $29130M 202,7x -41,7x
IRT Unlock Forecast - 30 Days FREE Trial $4219M 152,0x 1,2x
IVR Unlock Forecast - 30 Days FREE Trial $529M 13,1x 0,8x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1632M 40,3x 2,3x
IVT Unlock Forecast - 30 Days FREE Trial $2316M 20,7x 1,3x
JBGS Unlock Forecast - 30 Days FREE Trial $1327M -11,3x 0,7x
KBSR Unlock Forecast - 30 Days FREE Trial $21M x 0,1x
KIM Unlock Forecast - 30 Days FREE Trial $15385M 25,7x 1,5x
KIM-PL Unlock Forecast - 30 Days FREE Trial $14826M 24,8x 1,4x
KIM-PM Unlock Forecast - 30 Days FREE Trial $15178M 25,4x 1,4x
KIM-PN Unlock Forecast - 30 Days FREE Trial $41959M 70,2x 4,0x
KRC Unlock Forecast - 30 Days FREE Trial $5208M 23,8x 1,0x
KREF Unlock Forecast - 30 Days FREE Trial $700M 952,5x 0,6x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1409M x 1,1x
KRG Unlock Forecast - 30 Days FREE Trial $5124M 27,4x 1,5x
LADR Unlock Forecast - 30 Days FREE Trial $0M 15,1x 0,0x
LAMR Unlock Forecast - 30 Days FREE Trial $12969M 29,5x 14,3x
LAND Unlock Forecast - 30 Days FREE Trial $373M -54,4x 0,5x
LANDM Unlock Forecast - 30 Days FREE Trial $900M -119,7x 1,3x
LANDO Unlock Forecast - 30 Days FREE Trial $723M -104,0x 1,1x
LANDP Unlock Forecast - 30 Days FREE Trial $722M -103,5x 1,1x
LFT Unlock Forecast - 30 Days FREE Trial $122M 8,6x 0,5x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1131M 79,4x 4,9x
LINE Unlock Forecast - 30 Days FREE Trial $10740M x 1,2x
LOAN Unlock Forecast - 30 Days FREE Trial $62M 11,2x 1,4x
LTC Unlock Forecast - 30 Days FREE Trial $1836M 22,1x 1,9x
LXP Unlock Forecast - 30 Days FREE Trial $2757M 31,5x 1,3x
LXP-PC Unlock Forecast - 30 Days FREE Trial $14076M 160,9x 6,8x
MAA Unlock Forecast - 30 Days FREE Trial $17132M 30,0x 2,9x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6948M 12,2x 1,2x
MAC Unlock Forecast - 30 Days FREE Trial $4673M -64,7x 1,8x
MDRR Unlock Forecast - 30 Days FREE Trial $15M -8,9x 1,1x
MDRRP Unlock Forecast - 30 Days FREE Trial $28M -16,5x 2,3x
MDV Unlock Forecast - 30 Days FREE Trial $219M -24,6x 1,3x
MDV-PA Unlock Forecast - 30 Days FREE Trial $364M x 2,2x
MFA Unlock Forecast - 30 Days FREE Trial $1073M 8,4x 0,6x
MFAN Unlock Forecast - 30 Days FREE Trial $2651M 20,6x 1,5x
MFAO Unlock Forecast - 30 Days FREE Trial $2662M 20,7x 1,5x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2288M 17,8x 1,3x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2552M 19,9x 1,4x
MITN Unlock Forecast - 30 Days FREE Trial $757M 16,3x 1,4x
MITP Unlock Forecast - 30 Days FREE Trial $753M 16,2x 1,4x
MITT Unlock Forecast - 30 Days FREE Trial $232M 5,0x 0,4x
MITT-PA Unlock Forecast - 30 Days FREE Trial $685M 14,8x 1,3x
MITT-PB Unlock Forecast - 30 Days FREE Trial $672M 14,5x 1,3x
MITT-PC Unlock Forecast - 30 Days FREE Trial $750M 16,2x 1,4x
MKZR Unlock Forecast - 30 Days FREE Trial $133M x 2,0x
MPW Unlock Forecast - 30 Days FREE Trial $2755M -1,3x 0,6x
NHHS Unlock Forecast - 30 Days FREE Trial $340M 3,0x 1,4x
NHI Unlock Forecast - 30 Days FREE Trial $3661M 25,6x 2,5x
NHPAP Unlock Forecast - 30 Days FREE Trial $452M x 0,7x
NHPBP Unlock Forecast - 30 Days FREE Trial $454M x 0,7x
NLCP Unlock Forecast - 30 Days FREE Trial $292M 11,2x 0,7x
NLOP Unlock Forecast - 30 Days FREE Trial $439M x 0,9x
NLY Unlock Forecast - 30 Days FREE Trial $13285M -22,9x 1,0x
NNN Unlock Forecast - 30 Days FREE Trial $8033M 20,5x 1,8x
NREF Unlock Forecast - 30 Days FREE Trial $269M -28,2x 2,5x
NREF-PA Unlock Forecast - 30 Days FREE Trial $M x x
NSA Unlock Forecast - 30 Days FREE Trial $2861M 26,1x 2,8x
NTST Unlock Forecast - 30 Days FREE Trial $1524M 1247,7x 1,2x
NXDT Unlock Forecast - 30 Days FREE Trial $181M -1,9x 0,2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $681M x 0,9x
NXRT Unlock Forecast - 30 Days FREE Trial $878M 16,6x 2,5x
NYC Unlock Forecast - 30 Days FREE Trial $35M -0,1x 0,5x
NYMT Unlock Forecast - 30 Days FREE Trial $684M 11,0x 0,5x
NYMTG Unlock Forecast - 30 Days FREE Trial $2313M 37,2x 1,7x
NYMTI Unlock Forecast - 30 Days FREE Trial $2322M 37,4x 1,7x
NYMTL Unlock Forecast - 30 Days FREE Trial $2059M 33,1x 1,5x
NYMTM Unlock Forecast - 30 Days FREE Trial $2315M 37,3x 1,7x
NYMTN Unlock Forecast - 30 Days FREE Trial $2003M 32,2x 1,5x
NYMTZ Unlock Forecast - 30 Days FREE Trial $1660M 26,7x 1,2x
O Unlock Forecast - 30 Days FREE Trial $54646M 59,7x 1,4x
OHI Unlock Forecast - 30 Days FREE Trial $10939M 27,3x 2,3x
OLP Unlock Forecast - 30 Days FREE Trial $501M 25,4x 1,7x
ONL Unlock Forecast - 30 Days FREE Trial $170M -2,5x 0,2x
ORC Unlock Forecast - 30 Days FREE Trial $904M 141,0x 1,0x
OUT Unlock Forecast - 30 Days FREE Trial $3968M 36,9x 7,4x
PCH Unlock Forecast - 30 Days FREE Trial $3290M 79,0x 1,7x
PCOK Unlock Forecast - 30 Days FREE Trial $180M x 5,5x
PEB Unlock Forecast - 30 Days FREE Trial $1411M -21,5x 0,5x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2468M x 0,9x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2532M x 1,0x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2464M x 0,9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $2230M x 0,8x
PECO Unlock Forecast - 30 Days FREE Trial $5595M 81,3x 2,4x
PGRE Unlock Forecast - 30 Days FREE Trial $1392M -5,8x 0,5x
PINE Unlock Forecast - 30 Days FREE Trial $265M 169,3x 1,2x
PKST Unlock Forecast - 30 Days FREE Trial $518M -3,7x 0,7x
PLD Unlock Forecast - 30 Days FREE Trial $115261M 33,4x 2,2x
PLDGP Unlock Forecast - 30 Days FREE Trial $58098M 16,9x 1,1x
PLYM Unlock Forecast - 30 Days FREE Trial $705M 59,5x 1,2x
PMT Unlock Forecast - 30 Days FREE Trial $1077M 10,2x 0,6x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2111M 20,1x 1,1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2094M 19,9x 1,1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1630M 15,5x 0,9x
PMTU Unlock Forecast - 30 Days FREE Trial $2221M 21,1x 1,2x
PMTV Unlock Forecast - 30 Days FREE Trial $2213M 21,0x 1,2x
PMTW Unlock Forecast - 30 Days FREE Trial $2206M 21,0x 1,2x
PSA Unlock Forecast - 30 Days FREE Trial $51353M 28,4x 5,5x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3883M 2,1x 0,4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3791M 2,1x 0,4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4228M 2,3x 0,5x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3583M 2,0x 0,4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3469M 1,9x 0,4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3552M 2,0x 0,4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3421M 1,9x 0,4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $3052M 1,7x 0,3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2864M 1,6x 0,3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2883M 1,6x 0,3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $2953M 1,6x 0,3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2903M 1,6x 0,3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2955M 1,6x 0,3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $3031M 1,7x 0,3x
PSTL Unlock Forecast - 30 Days FREE Trial $0M 147,2x 0,0x
PW Unlock Forecast - 30 Days FREE Trial $3M -0,2x 0,6x
PW-PA Unlock Forecast - 30 Days FREE Trial $13M x 2,1x
RC Unlock Forecast - 30 Days FREE Trial $769M -13,0x 0,4x
RCB Unlock Forecast - 30 Days FREE Trial $4373M -44,3x 2,4x
RCC Unlock Forecast - 30 Days FREE Trial $4448M -45,2x 2,4x
RCD Unlock Forecast - 30 Days FREE Trial $4253M x 2,3x
RC-PC Unlock Forecast - 30 Days FREE Trial $2970M x 1,6x
RC-PE Unlock Forecast - 30 Days FREE Trial $2848M x 1,6x
REFI Unlock Forecast - 30 Days FREE Trial $279M 8,1x 0,9x
REG Unlock Forecast - 30 Days FREE Trial $13312M 22,1x 2,0x
REGCO Unlock Forecast - 30 Days FREE Trial $4284M x 0,6x
REGCP Unlock Forecast - 30 Days FREE Trial $4392M x 0,7x
REXR Unlock Forecast - 30 Days FREE Trial $10519M 33,1x 1,2x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5664M 17,8x 0,6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $5650M 17,8x 0,6x
RHP Unlock Forecast - 30 Days FREE Trial $10090M 37,7x 12,6x
RITM Unlock Forecast - 30 Days FREE Trial $6987M 8,7x 0,9x
RITM-PA Unlock Forecast - 30 Days FREE Trial $14226M 17,7x 1,8x
RITM-PB Unlock Forecast - 30 Days FREE Trial $14226M 17,7x 1,8x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13952M 17,4x 1,8x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13746M 17,1x 1,7x
RLJ Unlock Forecast - 30 Days FREE Trial $1159M 20,1x 0,5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3755M 65,0x 1,7x
ROIC Unlock Forecast - 30 Days FREE Trial $2248M 45,7x 1,7x
RPT Unlock Forecast - 30 Days FREE Trial $129M -0,8x 0,4x
RWT Unlock Forecast - 30 Days FREE Trial $17M 31,3x 0,0x
RWTN Unlock Forecast - 30 Days FREE Trial $70M x 0,1x
RWTO Unlock Forecast - 30 Days FREE Trial $69M x 0,1x
RWTP Unlock Forecast - 30 Days FREE Trial $69M x 0,1x
RYN Unlock Forecast - 30 Days FREE Trial $3676M 36,4x 1,9x
SACC Unlock Forecast - 30 Days FREE Trial $1174M 370,5x 5,3x
SACH Unlock Forecast - 30 Days FREE Trial $54M 21,3x 0,3x
SAFE Unlock Forecast - 30 Days FREE Trial $1166M 11,4x 0,5x
SBAC Unlock Forecast - 30 Days FREE Trial $20624M 23,5x -5,1x
SBRA Unlock Forecast - 30 Days FREE Trial $4557M 25,0x 1,7x
SCCC Unlock Forecast - 30 Days FREE Trial $1183M 361,5x 6,6x
SCCD Unlock Forecast - 30 Days FREE Trial $1029M 304,5x 5,7x
SCCE Unlock Forecast - 30 Days FREE Trial $923M 304,8x 5,1x
SCCF Unlock Forecast - 30 Days FREE Trial $907M 279,9x 5,1x
SCCG Unlock Forecast - 30 Days FREE Trial $911M 325,2x 5,1x
SELF Unlock Forecast - 30 Days FREE Trial $60M 24,0x 1,3x
SEVN Unlock Forecast - 30 Days FREE Trial $163M 10,5x 0,6x
SILA Unlock Forecast - 30 Days FREE Trial $1360M x 1,0x
SITC Unlock Forecast - 30 Days FREE Trial $495M 1,4x 1,0x
SKT Unlock Forecast - 30 Days FREE Trial $4080M 38,7x 6,4x
SLG Unlock Forecast - 30 Days FREE Trial $4942M -33,2x 1,3x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1889M x 0,5x
SOHO Unlock Forecast - 30 Days FREE Trial $18M -1,4x 0,4x
SOHOB Unlock Forecast - 30 Days FREE Trial $322M -21,4x 7,0x
SOHON Unlock Forecast - 30 Days FREE Trial $335M -21,8x 7,3x
SOHOO Unlock Forecast - 30 Days FREE Trial $333M -25,6x 7,2x
SPG Unlock Forecast - 30 Days FREE Trial $142M 23,1x 0,1x
SQFT Unlock Forecast - 30 Days FREE Trial $64M 1,2x 1,8x
SQFTP Unlock Forecast - 30 Days FREE Trial $191M 24,7x 5,4x
SQFTW Unlock Forecast - 30 Days FREE Trial $0M x 0,0x
STAG Unlock Forecast - 30 Days FREE Trial $6834M 29,2x 2,0x
STLY Unlock Forecast - 30 Days FREE Trial $20M 32,3x 0,5x
STRW Unlock Forecast - 30 Days FREE Trial $663M 111,4x 42,8x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0,4x
STWD Unlock Forecast - 30 Days FREE Trial $7898M 21,4x 1,2x
SUI Unlock Forecast - 30 Days FREE Trial $17082M 13,3x 2,3x
SUNS Unlock Forecast - 30 Days FREE Trial $145M 14,5x 0,8x
SVC Unlock Forecast - 30 Days FREE Trial $481M -2,2x 0,7x
TCI Unlock Forecast - 30 Days FREE Trial $412M 62,5x 0,5x
TFSA Unlock Forecast - 30 Days FREE Trial $202M x 0,0x
TPTA Unlock Forecast - 30 Days FREE Trial $563M x 3,3x
TRTX Unlock Forecast - 30 Days FREE Trial $790M 11,8x 0,7x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1477M 22,0x 1,4x
TWO Unlock Forecast - 30 Days FREE Trial $1289M -55,6x 0,6x
TWOD Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PA Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PB Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PC Unlock Forecast - 30 Days FREE Trial $M x x
UDR Unlock Forecast - 30 Days FREE Trial $16320M 123,7x 4,9x
UHT Unlock Forecast - 30 Days FREE Trial $574M 32,0x 3,5x
UMH Unlock Forecast - 30 Days FREE Trial $1273M 41,7x 1,4x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1924M 63,1x 2,1x
UNIT Unlock Forecast - 30 Days FREE Trial $1760M 49,9x -0,5x
VICI Unlock Forecast - 30 Days FREE Trial $35568M 12,9x 1,3x
VNO Unlock Forecast - 30 Days FREE Trial $9355M 10,7x 1,5x
VNO-PL Unlock Forecast - 30 Days FREE Trial $4291M 4,9x 0,7x
VNO-PM Unlock Forecast - 30 Days FREE Trial $4233M 4,8x 0,7x
VNO-PN Unlock Forecast - 30 Days FREE Trial $4226M 4,8x 0,7x
VNO-PO Unlock Forecast - 30 Days FREE Trial $3528M 4,0x 0,6x
VNORP Unlock Forecast - 30 Days FREE Trial $12723M 14,5x 2,1x
VRE Unlock Forecast - 30 Days FREE Trial $1867M -32,8x 1,7x
VTR Unlock Forecast - 30 Days FREE Trial $32526M 170,1x 2,8x
WELL Unlock Forecast - 30 Days FREE Trial $113811M 100,8x 3,2x
WHLR Unlock Forecast - 30 Days FREE Trial $-9M -4,1x -0,7x
WHLRD Unlock Forecast - 30 Days FREE Trial $-193M -86,0x -4,8x
WHLRL Unlock Forecast - 30 Days FREE Trial $-774M -344,1x -21,2x
WHLRP Unlock Forecast - 30 Days FREE Trial $-22M -9,8x -0,6x
WPC Unlock Forecast - 30 Days FREE Trial $14927M 44,5x 1,8x
WSR Unlock Forecast - 30 Days FREE Trial $693M 20,6x 1,6x
WY Unlock Forecast - 30 Days FREE Trial $18204M 65,3x 1,9x

Questions fréquemment posées - ALEXANDRIA REAL ESTATE EQUITIES, INC. Prévisions des stocks

Quelle est la précision des prévisions boursières de ALEXANDRIA REAL ESTATE EQUITIES, INC. ?

Our AI model demonstrates 39% historical accuracy for ARE predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

Quels sont les facteurs qui influencent les prévisions de prix des actions ?

Notre analyse prend en compte les indicateurs financiers de ALEXANDRIA REAL ESTATE EQUITIES, INC., les tendances sectorielles de Real Estate & Construction, le sentiment du marché, les indicateurs techniques, les données sur les bénéfices et les facteurs macroéconomiques qui influent sur la performance des actions.

Est-ce que ALEXANDRIA REAL ESTATE EQUITIES, INC. est un bon investissement en 2025 ?

D'après notre analyse de l'IA, ALEXANDRIA REAL ESTATE EQUITIES, INC. montre potentiel pour différents scénarios de marché. Tenez compte de votre tolérance au risque, de votre calendrier d'investissement et de la diversification de votre portefeuille avant de prendre des décisions d'investissement.

A quelle fréquence les prévisions ALEXANDRIA REAL ESTATE EQUITIES, INC. sont-elles mises à jour ?

Les prévisions boursières sont mises à jour quotidiennement à l'aide de données de marché en temps réel, ce qui vous permet de recevoir les prévisions et les informations d'investissement les plus récentes grâce à l'IA.

Vous voulez une analyse ALEXANDRIA REAL ESTATE EQUITIES, INC. plus avancée ?

Déverrouillez les fonctionnalités premium, y compris les objectifs de prix détaillés, les évaluations de risque, l'optimisation du portefeuille et les alertes en temps réel pour l'action ALEXANDRIA REAL ESTATE EQUITIES, INC..

Mon portefeuille

Tableau de bord des investissements

Chargement de votre portefeuille...